Delivery Order SPE2DB22D1106-SPE2DB25FEUV7
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,385.52 to supply Orgovyx 120 mg tablets (30-count units) with an ultimate completion date of September 11, 2025. This competitively awarded, non-set-aside contract features firm fixed-price pricing and reflects the DLA's ongoing pharmaceutical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $8,313.12 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on May 27, 2025, with an ultimate completion date of June 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates Conshohocken, Pennsylvania as the place of performance, which is also the location of AmerisourceBergen's corporate headquarters. The delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Orgovyx 120 mg tablets in a quantity of 30-unit packages. This competitive, non-set-aside contract was awarded on April 21, 2025, with a ceiling value of $1,385.52 and an ultimate completion date of May 12, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,156.56 on September 22, 2025, for the supply of Orgovyx 120 mg tablets (30-count units). This is a firm fixed-price, non-competitive delivery order with an ultimate completion date of October 14, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $2,771.04 by the Defense Logistics Agency for 30 tablets of Orgovyx 120 mg, with an ultimate completion date of September 9, 2025. This is a non-set-aside, competitively awarded contract representing a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The company...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 1, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's ability to compete...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Orgovyx 120 mg tablets in a package quantity of 30 units. This firm fixed-price delivery order, valued at $4,156.56, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order was competitively awarded with no set-aside designation and carries...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for Orgovyx 120 mg tablets in a quantity of 30 units, with a ceiling value of $2,771.04. This firm fixed-price delivery order, awarded on September 26, 2025, with an ultimate completion date of October 20, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a Delivery Order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,385.52 with firm fixed pricing and is scheduled for completion by August 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order, leveraging the company's extensive...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEUV7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-unit packaging) with a firm fixed price structure. The contract is non-competitive and competitively awarded with an ultimate completion date of July 16, 2025. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, serves as both the place of performance and the point of delivery for this pharmaceutical product. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. As a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, AmerisourceBergen supplies a wide range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. This particular delivery order exemplifies the company's role in fulfilling Defense Health Agency and related federal government medical supply requirements through the DLA's pharmaceutical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 6/24/25 |